Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
Medtronic
US Army
Merck
Moodys
US Department of Justice
Covington
Healthtrust
Daiichi Sankyo
Federal Trade Commission

Generated: January 16, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,402,949

« Back to Dashboard

Summary for Patent: 4,402,949
Title: Stable solutions of hydrogenated ergotalkaloids
Abstract:Stable solutions of (a) hydrogenated ergot alkaloids and (b) heparin as well as the salts thereof in a carrier medium comprising (c) water, (d) a mono- or poly-alcohol, and (e) urea or a pharmaceutically acceptable calcium or magnesium salt or ethylenediaminetetraacetic acid, and combinations thereof.
Inventor(s): Hartmann; Volker (Nuremberg, DE), Otto; Karl-Heinz (Kastl/Opf., DE), Patt; Ludwig (Nuremberg, DE)
Assignee: Sandoz Ltd. (Basel, CH)
Application Number:06/317,660
Patent Claim Types:
see list of patent claims
Composition; Formulation; Compound; Dosage form; Process;

Drugs Protected by US Patent 4,402,949

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 4,402,949

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany2945636Nov 12, 1979

International Patents Family Members for US Patent 4,402,949

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 371997 ➤ Subscribe
Austria A550480 ➤ Subscribe
Australia 535357 ➤ Subscribe
Australia 6426580 ➤ Subscribe
Belgium 886008 ➤ Subscribe
Canada 1165692 ➤ Subscribe
Switzerland 650930 ➤ Subscribe
Cyprus 1332 ➤ Subscribe
Germany 2945636 ➤ Subscribe
Germany 3068719 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cipla
US Department of Justice
QuintilesIMS
Federal Trade Commission
Dow
UBS
AstraZeneca
Harvard Business School
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot